Oaktree Acquisition Corp. III Life Sciences (OACC) Executive Compensation
Oaktree Acquisition Corp. III Life Sciences (OACC) is a publicly traded company on the Nasdaq, categorized under SIC 6770 (Blank Checks). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OACC
CIK: 2029769
Exchange: Nasdaq
SIC 6770: Blank Checks
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 7/15/2024 12:00:00 AM
Lead Engagement PartnerFatema Raza
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEFA14A | 2026-10-16 | — | DEFA14A | 0001193125-26-423331 | View SEC Doc Filr Page |
| 8-K | 2026-10-16 | 2026-10-16 | 8-K | 0001193125-26-423329 | View SEC Doc Filr Page |
| DEFA14A | 2026-10-15 | — | DEFA14A | 0001193125-26-422266 | View SEC Doc Filr Page |
| 8-K | 2026-10-15 | 2026-10-14 | 8-K | 0001193125-26-422263 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-02 | 2026-10-16 | DEF 14A | 0001193125-26-412601 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-21 | 2026-09-21 | PRE 14A | 0001193125-26-396720 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001950677-26-000024 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0000312069-26-000209 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-346973 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001688382-26-000017 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001193125-26-221814 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-11 | — | SCHEDULE 13G Filing | 0000886982-26-000205 | View SEC Doc Filr Page |
| 10-K | 2026-03-26 | 2025-12-31 | 10-K | 0001193125-26-126536 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-11 | — | SCHEDULE 13G/A Filing | 0000312069-26-000052 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001193125-25-280296 | View SEC Doc Filr Page |
| 3 | 2025-10-29 | 2025-10-29 | 3 | 0001193125-25-256847 | View SEC Doc Filr Page |
| 8-K | 2025-10-29 | 2025-10-29 | 8-K | 0001193125-25-256604 | View SEC Doc Filr Page |
| 3 | 2025-10-22 | 2025-10-17 | 3 | 0001193125-25-246855 | View SEC Doc Filr Page |
| 8-K | 2025-10-17 | 2025-10-17 | 8-K | 0001193125-25-242643 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-08-12 | — | SCHEDULE 13G/A Filing | 0000769993-25-000426 | View SEC Doc Filr Page |
| 10-Q | 2025-08-12 | 2025-06-30 | 10-Q | 0001193125-25-178570 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-07-15 | — | SCHEDULE 13G/A Filing | 0001104659-25-068094 | View SEC Doc Filr Page |
| 3 | 2025-06-16 | 2025-06-03 | 3 | 0000950170-25-086786 | View SEC Doc Filr Page |
| 8-K | 2025-06-06 | 2025-06-03 | 8-K | 0001193125-25-137105 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | 10-Q | 0001193125-25-119885 | View SEC Doc Filr Page |